AsOf

Recorded or changed on this day 2026-11-08

201–250 of 46,459 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 75,196,000,000 United States dollar
Abbott Laboratories total assets: 75,196,000,000 United States dollar, claim clm_4C989819EA90 · ended · superseded by clm_B767032D0C72 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,763,433,243 shares
Abbott Laboratories shares outstanding: 1,763,433,243 shares, claim clm_4CC142CFD436 · ended · superseded by clm_321196ABECC8 · 1 source (1 primary) · conf 0.95
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Abbott Laboratories · X · AbbottNews
Abbott Laboratories X: AbbottNews, claim clm_4CCD509B66A0 · new claim · 1 source · conf 0.60
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 8,658,000,000 United States dollar
Abbott Laboratories cash and equivalents: 8,658,000,000 United States dollar, claim clm_4D07CC32DA31 · ended · superseded by clm_B27DA681BF8C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 11,369,000,000 United States dollar
Abbott Laboratories quarterly revenue: 11,369,000,000 United States dollar, claim clm_4D4D4E6FC869 · ended · superseded by clm_EF0BC6C103EE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,189,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,189,000,000 United States dollar, claim clm_4D5842D1AFBC · ended · superseded by clm_F9C12EA9C926 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,511,000,000 United States dollar
Abbott Laboratories cash and equivalents: 7,511,000,000 United States dollar, claim clm_4D88D9F7190C · ended · superseded by clm_C0C2E64C6F88 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 41,247,000,000 United States dollar
Abbott Laboratories total assets: 41,247,000,000 United States dollar, claim clm_4DAF27B7700C · ended · superseded by clm_A72DE3456A35 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 39,497,000,000 United States dollar
Abbott Laboratories total assets: 39,497,000,000 United States dollar, claim clm_4DB8B69673CB · ended · superseded by clm_152F5F758C41 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,150,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,150,000,000 United States dollar, claim clm_4DDA3D71417E · ended · superseded by clm_33CB344232AF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,807,100,000 United States dollar
Abbott Laboratories quarterly revenue: 9,807,100,000 United States dollar, claim clm_4F0F9A9FCDF2 · ended · superseded by clm_B817BB7C1C39 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 69,043,000,000 United States dollar
Abbott Laboratories total assets: 69,043,000,000 United States dollar, claim clm_4FE2013C1FF1 · ended · superseded by clm_B337C7B6BC7D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 8,362,000,000 United States dollar
Abbott Laboratories operating income: 8,362,000,000 United States dollar, claim clm_504246A9C0D6 · ended · superseded by clm_492DDC48ED34 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,077,018,000 United States dollar
Abbott Laboratories cash and equivalents: 4,077,018,000 United States dollar, claim clm_507982939D85 · ended · superseded by clm_49FCEA1321DC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 4,532,000,000 United States dollar
Abbott Laboratories operating income: 4,532,000,000 United States dollar, claim clm_50D9545CB1D5 · ended · superseded by clm_3EFF550A655C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 9,594,000,000 United States dollar
Abbott Laboratories cash and equivalents: 9,594,000,000 United States dollar, claim clm_521772051B63 · ended · superseded by clm_B5EA4556B88D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 580,000,000 United States dollar
Abbott Laboratories quarterly research and development: 580,000,000 United States dollar, claim clm_5227340047B9 · ended · superseded by clm_99642DE8DD5D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,375,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,375,000,000 United States dollar, claim clm_53901BDE4225 · ended · superseded by clm_47F26EE33149 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,314,021,000 United States dollar
Abbott Laboratories quarterly revenue: 7,314,021,000 United States dollar, claim clm_53BF00022ED3 · ended · superseded by clm_79675DAFEFFB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,181,185,000 United States dollar
Abbott Laboratories quarterly operating income: 1,181,185,000 United States dollar, claim clm_5422E43B6140 · ended · superseded by clm_D67FB10D44D3 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · operating income · 8,053,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,435,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,435,000,000 United States dollar, claim clm_55CCFB617DE7 · ended · superseded by clm_021A4A96F575 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,552,643,385 shares
Abbott Laboratories shares outstanding: 1,552,643,385 shares, claim clm_55DE04E4C63E · ended · superseded by clm_4A1D932E0016 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 476,000,000 United States dollar
Abbott Laboratories quarterly net income: 476,000,000 United States dollar, claim clm_56D74673B58B · ended · superseded by clm_2BB6EFB82CB5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,738,946,799 shares
Abbott Laboratories shares outstanding: 1,738,946,799 shares, claim clm_570FAE00E73C · ended · superseded by clm_027756C1CA20 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 2,109,000,000 United States dollar
Abbott Laboratories quarterly operating income: 2,109,000,000 United States dollar, claim clm_57D24A3D8A74 · ended · superseded by clm_23A44C31565F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 73,354,000,000 United States dollar
Abbott Laboratories total assets: 73,354,000,000 United States dollar, claim clm_58DF422102D3 · ended · superseded by clm_7F56B9F9D8D3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,857,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,857,000,000 United States dollar, claim clm_59EC592653CE · ended · superseded by clm_E32F9485C0C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 716,000,000 United States dollar
Abbott Laboratories quarterly research and development: 716,000,000 United States dollar, claim clm_5AF0089A1631 · ended · superseded by clm_B9E52815E3A9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 41,662,000,000 United States dollar
Abbott Laboratories total assets: 41,662,000,000 United States dollar, claim clm_5B183F58E77F · ended · superseded by clm_285888A38ED0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 578,000,000 United States dollar
Abbott Laboratories quarterly research and development: 578,000,000 United States dollar, claim clm_5BDD75D9E730 · ended · superseded by clm_BB551BCBB517 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 38,603,000,000 United States dollar
Abbott Laboratories total equity: 38,603,000,000 United States dollar, claim clm_5BE6B18DE8F9 · ended · superseded by clm_C93071E72423 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,545,912,443 shares
Abbott Laboratories shares outstanding: 1,545,912,443 shares, claim clm_5CA03662740C · ended · superseded by clm_2777291C1D6A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 24,629,650,000 United States dollar
Abbott Laboratories total equity: 24,629,650,000 United States dollar, claim clm_5DCA28624EBB · ended · superseded by clm_6DF1F94B8785 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 41,725,000,000 United States dollar
Abbott Laboratories total assets: 41,725,000,000 United States dollar, claim clm_5EAB483532A7 · ended · superseded by clm_4DAF27B7700C · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · incorporated in · IL
Abbott Laboratories incorporated in: IL, claim clm_5EB4D6DCC26A · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · -329,000,000 United States dollar
Abbott Laboratories quarterly net income: -329,000,000 United States dollar, claim clm_5F39464983EE · ended · superseded by clm_DD829B82B38C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 672,000,000 United States dollar
Abbott Laboratories quarterly operating income: 672,000,000 United States dollar, claim clm_5F9689E3114D · ended · superseded by clm_8501CF976D96 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 654,000,000 United States dollar
Abbott Laboratories quarterly research and development: 654,000,000 United States dollar, claim clm_602C8D08E319 · ended · superseded by clm_9ED86C910D2E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 73,214,000,000 United States dollar
Abbott Laboratories total assets: 73,214,000,000 United States dollar, claim clm_603966F4450A · ended · superseded by clm_A3E39CBB1AE7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 375,000,000 United States dollar
Abbott Laboratories quarterly net income: 375,000,000 United States dollar, claim clm_604CF864E41B · ended · superseded by clm_B5440F9585CE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 76,250,000,000 United States dollar
Abbott Laboratories total assets: 76,250,000,000 United States dollar, claim clm_60A75BEF73AA · ended · superseded by clm_A40F2BAB5CB1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,816,665,000 United States dollar
Abbott Laboratories quarterly revenue: 9,816,665,000 United States dollar, claim clm_60A7CF8613BF · ended · superseded by clm_D9ABEC05FB6F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,964,000,000 United States dollar
Abbott Laboratories quarterly revenue: 9,964,000,000 United States dollar, claim clm_60D18C4ED290 · ended · superseded by clm_BC21405CF5E5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,406,585,000 United States dollar
Abbott Laboratories quarterly operating income: 1,406,585,000 United States dollar, claim clm_611637E5B583 · ended · superseded by clm_EE3783948414 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,741,000,000 United States dollar
Abbott Laboratories research and development: 2,741,000,000 United States dollar, claim clm_616A4BA20B30 · ended · superseded by clm_AD76C5C835C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 86,713,000,000 United States dollar
Abbott Laboratories total assets: 86,713,000,000 United States dollar, claim clm_61EE170DDFF9 · ended · superseded by clm_1E6184001C61 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,860,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,860,000,000 United States dollar, claim clm_6379D6E6764E · ended · superseded by clm_9ABE667349AF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 6,825,000,000 United States dollar
Abbott Laboratories operating income: 6,825,000,000 United States dollar, claim clm_6578DDE458E0 · ended · superseded by clm_551396362E4C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,896,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,896,000,000 United States dollar, claim clm_658B87946AB9 · ended · superseded by clm_BE85A98DAC5B · 1 source (1 primary) · conf 0.95

What the statuses mean